Cargando…
The diagnostic role of miR-122 in drug-induced liver injury: A systematic review and meta-analysis
BACKGROUND: Drug-induced liver injury (DILI) is a potentially severe adverse drug reaction especially in susceptible patients. But there are no sensitive or specific parameters to detecting DILI. The specific expression of miR-122 in the liver has been a hotspot in the evaluation of hepatic toxicity...
Autores principales: | Liu, Yiqi, Li, Ping, Liu, Liang, Zhang, Yilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310488/ https://www.ncbi.nlm.nih.gov/pubmed/30544438 http://dx.doi.org/10.1097/MD.0000000000013478 |
Ejemplares similares
-
Comparison of diagnostic accuracy of 3 diagnostic criteria combined with refined pathological scoring system for drug-induced liver injury
por: Liu, Yiqi, et al.
Publicado: (2020) -
Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
por: Amr, Khalda S., et al.
Publicado: (2017) -
Microfluidic system for near-patient extraction and detection of miR-122 microRNA biomarker for drug-induced liver injury diagnostics
por: Kersaudy-Kerhoas, Maïwenn, et al.
Publicado: (2022) -
Circulating Liver-Specific miR-122 as a Novel Potential Biomarker for Diagnosis of Cholestatic Liver Injury
por: Shifeng, Huang, et al.
Publicado: (2013) -
Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
por: Israelow, Benjamin, et al.
Publicado: (2014)